University Of Virginia
Clinical trials sponsored by University Of Virginia, explained in plain language.
-
New combo therapy could slash sepsis deaths in HIV patients
Disease control Not yet recruitingThis study tests whether adding steroids and a powerful antibiotic combination to standard care can help more people with HIV survive sepsis, a life-threatening infection. About 344 adults in sub-Saharan Africa will receive either standard treatment or the enhanced therapy. The g…
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Immune cells armed with antibody enter trial for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests whether immune cells (white blood cells) coated with a special antibody can safely attack and shrink tumors in people with metastatic breast or prostate cancer that has stopped responding to standard treatments. About 23 participants will receive week…
Phase: PHASE1, PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
Which ear gets the implant? new study aims to cut dizziness
Knowledge-focused Not yet recruitingThis study looks at 10 adults over 50 with hearing loss in both ears and one weak balance system. Researchers want to see if putting a cochlear implant in the ear with worse balance leads to less dizziness after surgery. Participants will be randomly assigned to get the implant i…
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC